FDA wants yet more data on Takeda diabetes drug alogliptin

Article Date: 26/04/2012 10:00
FDA wants yet more data on Takeda diabetes drug alogliptin

Vacancy Search

Quick job search

Advanced Search

Latest News

Surprise resurrection sees Aveo and Prima pining for the fjords

When it comes to dead parrots making comebacks it could not have got much more extreme than the severely depressed Aveo Oncology and Prima Biomed, whose apparently deceased oncology projects...

Upcoming events: a dosing decision for BioMarin, plus Roche to get Alzheimer’s data

Welcome to your weekly digest of approaching regulatory and clinical readouts. Data from BioMarin’s phase II trial of the achondroplasia project BMN 111, expected this month or next, will...
more news